Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Differential expression of activation markers by Mycobacterium tuberculosis-specific CD4+ T-cell distinguishes extrapulmonary from pulmonary tuberculosis and latent infection.

Silveira-Mattos PS, Barreto-Duarte B, Vasconcelos B, Fukutani KF, Vinhaes CL, Oliveira-de-Souza D, Ibegbu CC, Figueiredo MC, Sterling TR, Rengarajan J, Andrade BB.

Clin Infect Dis. 2019 Oct 30. pii: ciz1070. doi: 10.1093/cid/ciz1070. [Epub ahead of print]

PMID:
31665254
2.

High Frequencies of Caspase-3 Expressing Mycobacterium tuberculosis-Specific CD4+ T Cells Are Associated With Active Tuberculosis.

Adekambi T, Ibegbu CC, Cagle S, Ray SM, Rengarajan J.

Front Immunol. 2018 Jun 25;9:1481. doi: 10.3389/fimmu.2018.01481. eCollection 2018.

3.

CD4+ Foxp3+ T cells promote aberrant immunoglobulin G production and maintain CD8+ T-cell suppression during chronic liver disease.

Tedesco D, Thapa M, Gumber S, Elrod EJ, Rahman K, Ibegbu CC, Magliocca JF, Adams AB, Anania F, Grakoui A.

Hepatology. 2017 Feb;65(2):661-677. doi: 10.1002/hep.28894. Epub 2016 Dec 19.

4.

INTIMATE PARTNER VIOLENCE IS ASSOCIATED WITH INCREASED CD4+ T-CELL ACTIVATION AMONG HIV-NEGATIVE HIGH-RISK WOMEN.

Kalokhe AS, Ibegbu CC, Kaur SP, Amara RR, Kelley ME, Del Rio C, Stephenson R.

Pathog Immun. 2016 Spring;1(1):193-213.

5.

Induction of Th1-Biased T Follicular Helper (Tfh) Cells in Lymphoid Tissues during Chronic Simian Immunodeficiency Virus Infection Defines Functionally Distinct Germinal Center Tfh Cells.

Velu V, Mylvaganam GH, Gangadhara S, Hong JJ, Iyer SS, Gumber S, Ibegbu CC, Villinger F, Amara RR.

J Immunol. 2016 Sep 1;197(5):1832-42. doi: 10.4049/jimmunol.1600143. Epub 2016 Aug 1.

6.

Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans.

Quinn CP, Sabourin CL, Schiffer JM, Niemuth NA, Semenova VA, Li H, Rudge TL, Brys AM, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Parker SD, Babcock J, Keitel W, Poland GA, Keyserling HL, El Sahly H, Jacobson RM, Marano N, Plikaytis BD, Wright JG.

Clin Vaccine Immunol. 2016 Apr 4;23(4):326-38. doi: 10.1128/CVI.00696-15. Print 2016 Apr.

7.

Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.

Adekambi T, Ibegbu CC, Cagle S, Kalokhe AS, Wang YF, Hu Y, Day CL, Ray SM, Rengarajan J.

J Clin Invest. 2015 Sep;125(9):3723. doi: 10.1172/JCI83279. Epub 2015 Sep 1. No abstract available.

8.

Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.

Adekambi T, Ibegbu CC, Cagle S, Kalokhe AS, Wang YF, Hu Y, Day CL, Ray SM, Rengarajan J.

J Clin Invest. 2015 May;125(5):1827-38. doi: 10.1172/JCI77990. Epub 2015 Mar 30. Erratum in: J Clin Invest. 2015 Sep;125(9):3723.

9.

Systems biological analyses reveal the hepatitis C virus (HCV)-specific regulation of hematopoietic development.

Velazquez VM, Uebelhoer LS, Thapa M, Ibegbu CC, Courtney C, Bosinger SE, Magliocca JF, Adams AB, Kirk AD, Knechtle SJ, Kalman D, Suthar MS, Grakoui A.

Hepatology. 2015 Mar;61(3):843-56. doi: 10.1002/hep.27575. Epub 2015 Jan 30.

10.

Impaired degranulation and proliferative capacity of Mycobacterium tuberculosis-specific CD8+ T cells in HIV-infected individuals with latent tuberculosis.

Kalokhe AS, Adekambi T, Ibegbu CC, Ray SM, Day CL, Rengarajan J.

J Infect Dis. 2015 Feb 15;211(4):635-40. doi: 10.1093/infdis/jiu505. Epub 2014 Sep 9.

11.

Role of intestinal mucosal integrity in HIV transmission to infants through breast-feeding: the BAN study.

Kourtis AP, Ibegbu CC, Wiener J, King CC, Tegha G, Kamwendo D, Kumwenda J, Kaur SP, Flax V, Ellington S, Kacheche Z, Kayira D, Chasela C, van der Horst C, Jamieson DJ.

J Infect Dis. 2013 Aug 15;208(4):653-61. doi: 10.1093/infdis/jit221. Epub 2013 May 17.

12.

A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.

Quinn CP, Sabourin CL, Niemuth NA, Li H, Semenova VA, Rudge TL, Mayfield HJ, Schiffer J, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Brys AM, Hunt RE, Levesque D, Estep JE, Barnewall RE, Robinson DM, Plikaytis BD, Marano N; AVRP Laboratory Working Group.

Clin Vaccine Immunol. 2012 Nov;19(11):1730-45. doi: 10.1128/CVI.00324-12. Epub 2012 Aug 29.

13.

Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.

Adekambi T, Ibegbu CC, Kalokhe AS, Yu T, Ray SM, Rengarajan J.

PLoS One. 2012;7(4):e36046. doi: 10.1371/journal.pone.0036046. Epub 2012 Apr 24.

14.

Cellular immunity in breast milk: implications for postnatal transmission of HIV-1 to the infant.

Sabbaj S, Ibegbu CC, Kourtis AP.

Adv Exp Med Biol. 2012;743:161-9. doi: 10.1007/978-1-4614-2251-8_11. No abstract available.

PMID:
22454348
15.

Use of replication restricted recombinant vesicular stomatitis virus vectors for detection of antigen-specific T cells.

Moseley NB, Laur O, Ibegbu CC, Loria GD, Ikwuenzunma G, Jayakar HR, Whitt MA, Altman JD.

J Immunol Methods. 2012 Jan 31;375(1-2):118-28. doi: 10.1016/j.jim.2011.09.016. Epub 2011 Oct 8.

16.

Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adults.

Duraiswamy J, Ibegbu CC, Masopust D, Miller JD, Araki K, Doho GH, Tata P, Gupta S, Zilliox MJ, Nakaya HI, Pulendran B, Haining WN, Freeman GJ, Ahmed R.

J Immunol. 2011 Apr 1;186(7):4200-12. doi: 10.4049/jimmunol.1001783. Epub 2011 Mar 7.

17.

Prior exposure to an attenuated Listeria vaccine does not reduce immunogenicity: pre-clinical assessment of the efficacy of a Listeria vaccine in the induction of immune responses against HIV.

Whitney JB, Mirshahidi S, Lim SY, Goins L, Ibegbu CC, Anderson DC, Raybourne RB, Frankel FR, Lieberman J, Ruprecht RM.

J Immune Based Ther Vaccines. 2011 Jan 18;9:2. doi: 10.1186/1476-8518-9-2.

18.

Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling.

Radziewicz H, Ibegbu CC, Hon H, B├ędard N, Bruneau J, Workowski KA, Knechtle SJ, Kirk AD, Larsen CP, Shoukry NH, Grakoui A.

J Immunol. 2010 Mar 1;184(5):2410-22. doi: 10.4049/jimmunol.0902994. Epub 2010 Jan 25.

19.

Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection.

Radziewicz H, Ibegbu CC, Hon H, Osborn MK, Obideen K, Wehbi M, Freeman GJ, Lennox JL, Workowski KA, Hanson HL, Grakoui A.

J Virol. 2008 Oct;82(20):9808-22. doi: 10.1128/JVI.01075-08. Epub 2008 Jul 30.

20.

Differential expression of CD26 on virus-specific CD8(+) T cells during active, latent and resolved infection.

Ibegbu CC, Xu YX, Fillos D, Radziewicz H, Grakoui A, Kourtis AP.

Immunology. 2009 Mar;126(3):346-53. doi: 10.1111/j.1365-2567.2008.02899.x. Epub 2008 Jul 22.

21.

Postnatal stem/progenitor cells derived from the dental pulp of adult chimpanzee.

Cheng PH, Snyder B, Fillos D, Ibegbu CC, Huang AH, Chan AW.

BMC Cell Biol. 2008 Apr 22;9:20. doi: 10.1186/1471-2121-9-20.

22.

Virally induced CD4+ T cell depletion is not sufficient to induce AIDS in a natural host.

Milush JM, Reeves JD, Gordon SN, Zhou D, Muthukumar A, Kosub DA, Chacko E, Giavedoni LD, Ibegbu CC, Cole KS, Miamidian JL, Paiardini M, Barry AP, Staprans SI, Silvestri G, Sodora DL.

J Immunol. 2007 Sep 1;179(5):3047-56.

23.

Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.

Kourtis AP, Ibegbu CC, Theiler R, Xu YX, Bansil P, Jamieson DJ, Lindsay M, Butera S, Duerr A.

J Infect Dis. 2007 Apr 1;195(7):965-72. Epub 2007 Feb 20.

PMID:
17330786
24.

Antigen-specific CD4+ T cells recognize epitopes of protective antigen following vaccination with an anthrax vaccine.

Laughlin EM, Miller JD, James E, Fillos D, Ibegbu CC, Mittler RS, Akondy R, Kwok W, Ahmed R, Nepom G.

Infect Immun. 2007 Apr;75(4):1852-60. Epub 2007 Feb 5. Erratum in: Infect Immun. 2007 Sep;75(9):4670.

25.

Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression.

Radziewicz H, Ibegbu CC, Fernandez ML, Workowski KA, Obideen K, Wehbi M, Hanson HL, Steinberg JP, Masopust D, Wherry EJ, Altman JD, Rouse BT, Freeman GJ, Ahmed R, Grakoui A.

J Virol. 2007 Mar;81(6):2545-53. Epub 2006 Dec 20.

26.

A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells.

Liu Y, Goff RD, Zhou D, Mattner J, Sullivan BA, Khurana A, Cantu C 3rd, Ravkov EV, Ibegbu CC, Altman JD, Teyton L, Bendelac A, Savage PB.

J Immunol Methods. 2006 May 30;312(1-2):34-9. Epub 2006 Mar 6.

PMID:
16647712
27.

Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57.

Ibegbu CC, Xu YX, Harris W, Maggio D, Miller JD, Kourtis AP.

J Immunol. 2005 May 15;174(10):6088-94. Erratum in: J Immunol. 2006 Jun 15;176(12):7787.

28.

Emerging prospects for the disease-modifying treatment of Alzheimer's disease.

Walker LC, Ibegbu CC, Todd CW, Robinson HL, Jucker M, LeVine H 3rd, Gandy S.

Biochem Pharmacol. 2005 Apr 1;69(7):1001-8. Review.

PMID:
15763538
29.

SHIV-KB9 infection of rhesus monkeys does not always cause disease-contribution of host immune factors and thymic output.

Kourtis AP, Ibegbu CC, Scinicariello F, Oh CY, McClure HM.

Virology. 2002 Nov 10;303(1):47-57.

30.

Effects of different HIV strains on thymic epithelial cultures.

Kourtis AP, Ibegbu CC, Scinicarrielo F, Lee FK.

Pathobiology. 2001;69(6):329-32.

PMID:
12324710
31.

Decreases in CD5+ B lymphocytes in children with the DiGeorge anomaly.

Kourtis AP, Ibegbu CC, Lee FK, Vogler L, Philips K, Nahmias AJ.

Scand J Immunol. 1997 Sep;46(3):281-3.

32.

Recurrent multifocal osteomyelitis due to Mycobacterium avium complex.

Kourtis AP, Ibegbu CC, Snitzer JA, Nesheim SR.

Clin Infect Dis. 1996 Nov;23(5):1194-5. No abstract available.

PMID:
8922838
33.

CD5+ B cells in normal newborns and infants, and in those with HIV and intrauterine infections.

Ibegbu CC, Nahmias AJ, Spira TJ, Stoll BJ, Jones B, Symbas N, Nesheim S, Mendez H, Keyserling H, Lee FK.

Ann N Y Acad Sci. 1992 May 4;651:572-5. No abstract available.

PMID:
1376079
34.

Analysis of synergism/antagonism between HIV-1 antibody-positive human sera and soluble CD4 in blocking HIV-1 binding and infectivity.

Kennedy MS, Orloff S, Ibegbu CC, Odell CD, Maddon PJ, McDougal JS.

AIDS Res Hum Retroviruses. 1991 Dec;7(12):975-81.

PMID:
1687500
35.

Structural features of CD4 required for binding to HIV.

Ibegbu CC, Kennedy MS, Maddon PJ, Deen KC, Hicks D, Sweet RW, McDougal JS.

J Immunol. 1989 Apr 1;142(7):2250-6.

PMID:
2538505

Supplemental Content

Loading ...
Support Center